John R. Mascola

2 ta ish

National Institutes of Health

1. An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

   Lisa A. Jackson, Evan J. Anderson, Nadine Rouphael +30

   Maqola20203 iqtibos

   ABIABI:AkademIndex/2026.other.373856

2. Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial

   Melinda Hamer, Katherine V. Houser, Amelia R. Hofstetter +52

   Maqola20232 iqtibos

   ABIABI:AkademIndex/2026.other.346076